Evidence map›Paper›PMID 42192176›Full record

ArticleScientific reports2026

Design, click-based synthesis, molecular docking, molecular dynamics and anticancer activity of new isoindoline-1,3-dione- triazole-glycopyranosyl hybrids.

Mohamed N El-Bayaa, Asmaa L Alanzy, Fahad M Alminderej, May A El-Manawaty, Sabri Messaoudi, Wael A El-Sayed

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mohamed N El-BayaaDepartment of Chemistry, College of Science, Qassim University, Buraidah, 51452, Saudi Arabia.
Asmaa L AlanzyDepartment of Chemistry, College of Science, Qassim University, Buraidah, 51452, Saudi Arabia.
Fahad M AlminderejDepartment of Chemistry, College of Science, Qassim University, Buraidah, 51452, Saudi Arabia. f.Alminderej@qu.edu.sa.
May A El-ManawatyPharmacognosy Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Cairo, 12622, Egypt.
Sabri MessaoudiDepartment of Chemistry, College of Science, Qassim University, Buraidah, 51452, Saudi Arabia.
Wael A El-SayedPhotochemistry Department, National Research Centre, Dokki, Giza, 12622, Egypt. waelshendy@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The application of simulated research approaches for the discovery and development of novel compounds as promising cancer drug candidates have still garnered widespread attention as an important goal in medicinal chemistry. In such context, a novel derived series of modified glycosides based on an isoindole-1,2,3-triazole-1,4-disubstituted-aryl hybrid system were synthesized from the terminal acetylenic compound (prepared from propargylation of 2-(4-hydroxyphenyl)isoindoline-1,3-dione (1)) and different glycosyl azides via click-based strategy. Furthermore, the afforded acetylated Iso-idolinedione-N

Indexed as

Antineoplastic AgentsDrug DesignGlycosidesIsoindolesMolecular Docking SimulationTriazolesCell Line, TumorClick ChemistryErbB ReceptorsHumansMolecular Dynamics SimulationStructure-Activity RelationshipAntineoplastic AgentsErbB ReceptorsGlycosidesIsoindolesTriazoles1,2,3-triazolesCancerClick chemistryCytotoxicityGlycosidesIsoindoleMolecular dynamics

Identifiers

PMID42192176
PMCPMC13270154

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.